(Q40580252)

21 September 2017

title

The dexamethasone suppression test and CSF-5-HIAA in relation to suicidality and depression in suicide attempters (English)

1 reference

dexamethasone suppression test

21 September 2017

0 references

0 references

0 references

0 references

1 reference

Asa Westrin

1

1 reference

21 September 2017

Anders Niméus

series ordinal

2

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

21 September 2017

1 reference

21 September 2017

volume

18

1 reference

21 September 2017

issue

4

1 reference

21 September 2017

page(s)

166-171

1 reference

A New Depression Scale Designed to be Sensitive to Change

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

Neural circuits mediating stress

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

Negative and depressive symptoms in suicidal schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

High delta sleep-inducing peptide-like immunoreactivity in plasma in suicidal patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

POSSIBILITY OF A BIOCHEMICAL TEST FOR SUICIDAL POTENTIAL: AN ANALYSIS OF ENDOCRINE FINDINGS PRIOR TO THREE SUICIDES.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

Biochemical markers in suicidal patientsInvestigations with cerebrospinal fluid amine metabolites and neuroendocrine tests

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

CSF-amine metabolites in depression, dementia and in controls

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

The dexamethasone suppression test in suicidal patients with unipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

The dexamethasone suppression test as an indicator of suicide: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

Further Evaluation of Urinary 17-Hydroxycorticosteroids in Suicidal Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

Adrenocortical function and suicidal behavior in depressive disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

The dexamethasone suppression test and suicide attempts

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

Changes of cerebrospinal fluid monoamine metabolites during long-term antidepressant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

Suicide and the dexamethasone suppression test in unipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

The dexamethasone suppression test in violent suicide attempters with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

The suicide assessment scale: an instrument assessing suicide risk of suicide attempters

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

Biochemistry and suicidal behavior in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

Neuroendocrine risk factors of suicidal behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

Monoamine metabolites in CSF and suicidal behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

Faulty cortisol/serotonin interplay. Psychopathological and biological characterisation of a new, hypothetical depression subtype (SeCA depression)

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900044-0

7 January 2021

10.1016/S0924-9338(03)00044-0

Identifiers

DOI

1 reference

21 September 2017

1 reference